at home semaglutide injections Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes Oral vs Injectable Semaglutide for

Status Not FDA-approved, research-use-only, and WADA-banned in sport

A 17% Reduction in Overall Cancer Risk A landmark study published in JAMA Oncology (Dai H et al., August 2025), drawing on data from 14 health systems encompassing approximately 20 million patients, found that adults with obesity who were prescribed GLP-1 receptor agonists had a 17% lower risk of developing cancer compared to carefully matched non-users

If applied to areas with frequent joint movement, friction may cause it to detach or the needles to break

Common uses include lipid metabolism studies, cardiovascular research

Once tagged, the receptor attracts proteins called beta-arrestins